Barclays holds Sell on Pfizer despite 4.8% upside to consensus
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
Barclays analyst Emily Field maintained a Sell rating on Pfizer (PFE) with a price target of $25.00. This is in contrast to the current analyst consensus of a Hold with an average price target of $30.28. Pfizer recently reported quarterly revenue of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context